Legara, Efipanio G.
HRN: 07-57-48 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2023
CEFUROXIME 750MG (VIAL)
04/20/2023
04/26/2023
IV
750mg
Q8Hrs
AGN
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes